https://www.fiercebiotech.com/biotech/boehringer-ingelheim-and-epizyme-launch-300m-precision-oncology-program
Boehringer Ingelheim and Epizyme launch $300M precision oncology program | Fierce Biotech
Nov 15, 2018 - In a worldwide collaboration worth up to $300 million or more, Boehringer Ingelheim is expanding its precision oncology programs by tapping Epizyme for...
precision oncology programboehringer ingelheimlaunch